Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cooper Neurological Institute (CNI) is a comprehensive center for neurological and neurosurgical care, serving as a specialized division of Cooper University Health Care in Southern New Jersey. The institute provides advanced diagnostic and treatment services for a wide range of conditions, including stroke, brain tumors, epilepsy, and movement disorders. CNI is recognized for its Level 4 Epilepsy Center and its Joint Commission-certified Comprehensive Stroke Center, which is a regional leader in mechanical thrombectomy. It integrates clinical excellence with academic research and clinical trials, offering patients access to cutting-edge therapies and innovative surgical techniques. The institute's multidisciplinary team includes neurosurgeons, neurologists, and specialized support staff dedicated to improving patient outcomes through personalized care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cooper Neurological Institute.